As of Sep 18
| -0.02 / -0.93%|
The 2 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +111.27% increase from the last price of 2.13.
The current consensus among 3 polled investment analysts is to Hold stock in Sunesis Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.